MedPath

Creatine on Bone Mass in Postmenopausal Women

Not Applicable
Conditions
Postmenopausal Women
Interventions
Dietary Supplement: dextrose (placebo)
Dietary Supplement: Creatine supplementation
Registration Number
NCT01472393
Lead Sponsor
University of Sao Paulo
Brief Summary

Animal, in vitro and small-scale studies have suggested that creatine supplementation may augment bone mass. This clinical trial aims to investigate the effects of a 2-year creatine supplementation protocol on bone mass in postmenopausal women.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
200
Inclusion Criteria
  • healthy postmenopausal women
  • T-score at lumbar spine, or femoral neck or total femur of between -1SD and -2.5SD
Read More
Exclusion Criteria
  • drugs or dietary supplements that may affect bone metabolism (e.g., bisphosphonates, AINEs, hormone replacement therapy, calcium, vitamin D, creatine supplementation)
  • low BMI (< 18.5 Kg/m2).
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Placebodextrose (placebo)-
Creatine supplementationCreatine supplementation-
Primary Outcome Measures
NameTimeMethod
bone mineral density (BMD)12 and 24 months
Secondary Outcome Measures
NameTimeMethod
bone microarchitecture12 and 24 months
history of falls24 months
muscle function12 and 24 months
laboratory parameters12 and 24 months
bone markers12 and 24 months

will include CTX and P1NP

lean mass12 and 24 months

Trial Locations

Locations (1)

University of Sao Paulo - School of Medicine

🇧🇷

Sao Paulo, Brazil

© Copyright 2025. All Rights Reserved by MedPath